Media Summary: At the MAP Manufacturing Workshop, the new drug delivery platform has been described as “nothing short of revolutionary” and “a ... Given the fact that MAP is a new type of drug delivery platform, a number of challenges have still to be overcome before market ... Join our webinar and get insight in the development of an Interferon-ß containing MAP (Micro Array

Microarray Patches For High Dose - Detailed Analysis & Overview

At the MAP Manufacturing Workshop, the new drug delivery platform has been described as “nothing short of revolutionary” and “a ... Given the fact that MAP is a new type of drug delivery platform, a number of challenges have still to be overcome before market ... Join our webinar and get insight in the development of an Interferon-ß containing MAP (Micro Array Logan Melot explores new tech in vaccine delivery via Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second WINMAP Microarray Patch Technology Platform (CH Sub)

MOST PRP MOST PRP FAILS BEFORE IT EVEN REACHES THE PATIENT. Not because the science is flawed—but because the ...

Photo Gallery

Microarray Patches for High-dose Drug Delivery: Targeting Global Healthcare Challenges
Microarray patches for high dose drug delivery: Targeting global healthcare challenges
Hilleman Laboratories MR Microarray Patch
Microneedle Array Patches – Advantages
Micro Array Patches (MAP)
Vaxxas’ High Density Micro‐Projection Array Patch –Delivering the Future of Needle‐Free Vaccination
Microneedle Array Patches – Challenges
{Nov 2022] Micro Array Patches
[Nov 2022] Micro Array Patches - Background and Case Study
Microarray Patches to Improve Vaccine Delivery and Address Health Equity:  But Will People Use Them?
How, where and when are we going to use microarray patches to deliver measles and rubella vaccines?
WINMAP Microarray Patch Technology Platform (CH Sub)
View Detailed Profile
Microarray Patches for High-dose Drug Delivery: Targeting Global Healthcare Challenges

Microarray Patches for High-dose Drug Delivery: Targeting Global Healthcare Challenges

by Prof.Dr. Ryan Donnelly.

Microarray patches for high dose drug delivery: Targeting global healthcare challenges

Microarray patches for high dose drug delivery: Targeting global healthcare challenges

Professor Ryan Donnelly.

Hilleman Laboratories MR Microarray Patch

Hilleman Laboratories MR Microarray Patch

... trials to show that

Microneedle Array Patches – Advantages

Microneedle Array Patches – Advantages

At the MAP Manufacturing Workshop, the new drug delivery platform has been described as “nothing short of revolutionary” and “a ...

Micro Array Patches (MAP)

Micro Array Patches (MAP)

Micro Array

Vaxxas’ High Density Micro‐Projection Array Patch –Delivering the Future of Needle‐Free Vaccination

Vaxxas’ High Density Micro‐Projection Array Patch –Delivering the Future of Needle‐Free Vaccination

Featuring: Angus Forster (Vaxxas)

Microneedle Array Patches – Challenges

Microneedle Array Patches – Challenges

Given the fact that MAP is a new type of drug delivery platform, a number of challenges have still to be overcome before market ...

{Nov 2022] Micro Array Patches

{Nov 2022] Micro Array Patches

LTS Micro Array

[Nov 2022] Micro Array Patches - Background and Case Study

[Nov 2022] Micro Array Patches - Background and Case Study

Join our webinar and get insight in the development of an Interferon-ß containing MAP (Micro Array

Microarray Patches to Improve Vaccine Delivery and Address Health Equity:  But Will People Use Them?

Microarray Patches to Improve Vaccine Delivery and Address Health Equity: But Will People Use Them?

Logan Melot explores new tech in vaccine delivery via

How, where and when are we going to use microarray patches to deliver measles and rubella vaccines?

How, where and when are we going to use microarray patches to deliver measles and rubella vaccines?

Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second

WINMAP Microarray Patch Technology Platform (CH Sub)

WINMAP Microarray Patch Technology Platform (CH Sub)

WINMAP Microarray Patch Technology Platform (CH Sub)

HOW DO YOU MAKE HIGH DOSE, HIGH CONCENTRATION PRP?

HOW DO YOU MAKE HIGH DOSE, HIGH CONCENTRATION PRP?

MOST PRP MOST PRP FAILS BEFORE IT EVEN REACHES THE PATIENT. Not because the science is flawed—but because the ...